Myovant Sciences Ltd. (NYSE: MYOV) is -19.27% lower on its value in year-to-date trading and has touched a low of $4.14 and a high of $19.58 in the current 52-week trading range. The MYOV stock was last observed hovering at around $11.48 in the last trading session, with the day’s gains setting it 1.05%.
Currently trading at $12.53, the stock is 13.20% and 31.11% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.04 million and changing 9.15% at the moment leaves the stock 28.79% off its SMA200. MYOV registered -31.15% loss for a year compared to 6-month gain of 116.03%. The firm has a 50-day simple moving average (SMA 50) of $9.62 and a 200-day simple moving average (SMA200) of $11.20.
The stock witnessed a 46.38% loss in the last 1 month and extending the period to 3 months gives it a -3.76%, and is 6.37% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.01% over the week and 8.49% over the month.
Distance from 52-week low is 202.66% and -36.01% from its 52-week high.
Myovant Sciences Ltd. (MYOV) Analyst Forecasts
Myovant Sciences Ltd. quarterly earnings per share for the current quarter are estimated at -$0.8.The EPS is expected to shrink by -71.10% this year.
Myovant Sciences Ltd. (MYOV) Top Institutional Holders
93 institutions hold shares in Myovant Sciences Ltd. (MYOV), with 53.79M shares held by insiders accounting for 59.91% while institutional investors hold 93.88% of the company’s shares. The shares outstanding are 96.48M, and float is at 32.52M with Short Float at 9.31%. Institutions hold 37.63% of the Float.
The top institutional shareholder in the company is Bellevue Group AG with over 4.82 million shares valued at $74.73 million. The investor’s holdings represent 5.36% of the MYOV Shares outstanding. As of Dec 30, 2019, the second largest holder is Janus Henderson Group PLC with 4.72 million shares valued at $73.25 million to account for 5.26% of the shares outstanding. The other top investors are Eventide Asset Management LLC which holds 4.13 million shares representing 4.60% and valued at over $64.04 million, while Wellington Management Company, LLP holds 4.03% of the shares totaling 3.61 million with a market value of $56.09 million.
Myovant Sciences Ltd. (MYOV) Insider Activity
A total of 52 insider transactions have happened at Myovant Sciences Ltd. (MYOV) in the last six months, with sales accounting for 6 and purchases happening 46 times. The most recent transaction is an insider purchase by Sumitomo Chemical Co., Ltd., the company’s 10% Owner. SEC filings show that Sumitomo Chemical Co., Ltd. bought 50,000 shares of the company’s common stock on May 04 at a price of $11.50 per share for a total of $574870.0. Following the purchase, the insider now owns 48.15 million shares.
Myovant Sciences Ltd. disclosed in a document filed with the SEC on May 01 that Sumitomo Chemical Co., Ltd. (10% Owner) bought a total of 50,000 shares of the company’s common stock. The trade occurred on May 01 and was made at $11.38 per share for $569180.0. Following the transaction, the insider now directly holds 48.1 million shares of the MYOV stock.
Still, SEC filings show that on Apr 30, Sumitomo Chemical Co., Ltd. (10% Owner) acquired 50,000 shares at an average price of $12.08 for $603825.0. The insider now directly holds 48,047,693 shares of Myovant Sciences Ltd. (MYOV).
Myovant Sciences Ltd. (MYOV): Who are the competitors?
The company’s main competitors (and peers) include PDL BioPharma Inc. (PDLI) that is trading 6.13% up over the past 12 months. Short interest in the company’s stock has risen 0.99% from the last report on Mar 12, 2020 to stand at a total of 3.0 million short shares sold with a short interest ratio of 2.9.